进一步优化治疗可手术激素受体敏感乳腺癌患者的护理
Alexandra Thomas1, Erica L Mayer2, Angela DeMichele3
1Duke Cancer Institute, Duke University, Durham, NC.
概括
全球合作是改善激素敏感,可手术的乳腺癌治疗结果的关键. 协调一致的努力提高了这种特定类型癌症患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 激素敏感的可操作乳腺癌需要全球协调的研究努力.
- 改善患者的治疗结果需要在治疗和研究中采用标准化的方法.
研究的目的:
- 强调协调全球合作的重要性.
- 突出国际合作对激素敏感可手术乳腺癌结果的影响.
主要方法:
- 这项研究综合了国际研究倡议的发现.
- 它分析了合作项目的数据,重点关注激素敏感的可操作乳腺癌.
主要成果:
- 协调的全球合作表明对治疗疗效有显著的积极影响.
- 标准化研究协议导致更可靠和可比的结果.
结论:
- 国际合作和协调战略对于促进对激素敏感可手术乳腺癌患者的护理至关重要.
- 未来的研究应该优先考虑全球伙伴关系,以加速乳腺癌治疗的进展.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


